ergine
Megjelenés
| Clinical data | |
|---|---|
| Other names | Lysergic acid amide; LSA; LAA; ᴅ-Lysergic acid amide; ᴅ-Lysergamide, d-Lysergamide; LA-111; "Lacy"; 6-Methyl-9,10-didehydroergoline-8β-carboxamide |
| Pregnancy category |
|
| Routes of administration | Oral, intramuscular injection, subcutaneous injection |
| Drug class | Serotonin receptor agonist; Serotonergic psychedelic; Hallucinogen; Sedative |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Onset of action | 0.3–3 h (morn. glory seeds) |
| Duration of action | 4–10 h (morn. glory seeds) |
| Excretion | Urine |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C16H17N3O |
| Molar mass | 267.332 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 135 °C (275 °F) Decomposes |
| |
| |
| (verify) | |
Főnév
ergine (tsz. ergines)